SMS Lifescience receives EIR from USFDA for Kazipally Unit

18 Jun 2018 Evaluate

SMS Lifescience India has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection conducted in April 2018, at its manufacturing facility - Unit-I, located at Kazipally, Medak district in Hyderabad.

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.

Haleos Labs Share Price

1335.00 16.20 (1.23%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×